Technological advancements in the field of a breast biopsy and the rising incidence of breast cancer are the major factors driving the growth of this market. Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other significant factors driving the growth of this market.
The report Breast
Biopsy Market is projected to reach USD 1,094 million by 2025 from USD
725 million in 2020, at a CAGR of 8.6% during the forecast period.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805
Market Segmentation:-
Based on the product, the breast biopsy market is
segmented into biopsy needles, guidance systems, biopsy tables, localization
wires, assay kits, liquid biopsy instruments, and other products. In 2019, the
biopsy needles held significant share of the market. The major share of this
segment is primarily attributed to the rising incidence of breast cancer and
the growing breast cancer diagnosis rate in developing countries.
Based on guidance, the Breast Biopsy Devices Market is
segmented into image-guided biopsy and liquid biopsy. The liquid biopsy segment
is further divided into NGS-based, PCR-based, and Microarray-based biopsy.
Among these, the NGS-based biopsy segment is expected to register significant
growth over the forecast period.
Based on type, the Breast Biopsy Devices Market is
segmented into needle breast biopsy, open surgical breast biopsy, and liquid
breast biopsy. In 2019, the needle breast biopsy held a major share of the
breast biopsy market. Needle biopsy has replaced conventional excisional biopsy
as the standard diagnostic procedure for breast cancer.
Key Market Drivers: -
1 Growing incidence of breast cancer
2 Increasing number of breast cancer
screening programs
3 Increasing demand for minimally
invasive and non-invasive procedures
4 Growing awareness regarding early
detection of breast cancer
5 Improved reimbursement scenario
Regional Analysis:-
The breast biopsy market is segmented into five regional
segments, namely, North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa. The North American region accounted for the largest
share of the breast biopsy market in 2019.
Speak
To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=189011805
Top
Key Players:-
The major players operating in the breast biopsy market
are Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation
(US), Merit Medical Systems (US), QIAGEN (Netherlands), Biocept Inc. (US),
Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland),
Menarini Silicon Biosystems, Spa (Italy), Exact Sciences Corporation (US),
Illumina, Inc. (US), and Fluxion Biosciences Inc (US), among others.
No comments:
Post a Comment